• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Carbon source-dependent capsule thickness regulation in Streptococcus pneumoniae.
 

Carbon source-dependent capsule thickness regulation in Streptococcus pneumoniae.

Options
  • Details
  • Files
BORIS DOI
10.48350/190361
Publisher DOI
10.3389/fcimb.2023.1279119
PubMed ID
38094742
Description
BACKGROUND

The polysaccharide capsule of Streptococcus pneumoniae plays a major role in virulence, adherence to epithelial cells, and overall survival of the bacterium in the human host. Galactose, mannose, and N-acetylglucosamine (GlcNAc) are likely to be relevant for metabolization in the nasopharynx, while glucose is the primary carbon source in the blood. In this study, we aim to further the understanding of the influence of carbon sources on pneumococcal growth, capsule biosynthesis, and subsequent adherence potential.

METHODS

We tested the growth behavior of clinical wild-type and capsule knockout S. pneumoniae strains, using galactose, GlcNAc, mannose, and glucose as carbon source for growth. We measured capsule thickness and quantified capsule precursors by fluorescein isothiocyanate (FITC)-dextran exclusion assays and 31P-nuclear magnetic resonance measurements, respectively. We also performed epithelial adherence assays using Detroit 562 cells and performed a transcriptome analysis (RNA sequencing).

RESULTS

We observed a reduced growth in galactose, mannose, and GlcNAc compared to growth in glucose and found capsular size reductions in mannose and GlcNAc compared to galactose and glucose. Additionally, capsular precursor measurements of uridine diphosphate-(UDP)-glucose and UDP-galactose showed less accumulation of precursors in GlcNAc or mannose than in glucose and galactose, indicating a possible link with the received capsular thickness measurements. Epithelial adherence assays showed an increase in adherence potential for a pneumococcal strain, when grown in mannose compared to glucose. Finally, transcriptome analysis of four clinical isolates revealed not only strain specific but also common carbon source-specific gene expression.

CONCLUSION

Our findings may indicate a careful adaption of the lifestyle of S. pneumoniae according to the monosaccharides encountered in the respective human niche.
Date of Publication
2023
Publication Type
Article
Subject(s)
500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health
500 Science > 540 Chemistry
Keyword(s)
Streptococcus pneumoniae adherence capsule monosaccharides precursor transcriptome
Language(s)
en
Contributor(s)
Werren, Joel Pascal
Institut für Infektionskrankheiten (IFIK) - Microbiome
Institut für Infektionskrankheiten (IFIK) - Forschung
Institut für Infektionskrankheiten (IFIK)
Mostacci, Nadja
Gjuroski, Ilche
DCBP Gruppe Prof. Furrer
Departement für Chemie, Biochemie und Pharmazie (DCBP) Universität Bern
Holivololona, Lalaina
Institut für Infektionskrankheiten (IFIK) - Forschung
Institut für Infektionskrankheiten (IFIK) - Microbiome
Institut für Infektionskrankheiten (IFIK)
Troxler, Lukas
Institut für Infektionskrankheiten, Labor für Klinische Pharmakologie
Institut für Infektionskrankheiten (IFIK)
Institut für Infektionskrankheiten (IFIK) - Forschung
Hathaway, Lucy Janeorcid-logo
Institut für Infektionskrankheiten (IFIK) - Forschung
Institut für Infektionskrankheiten (IFIK) - Pneumococcal Biology
Institut für Infektionskrankheiten (IFIK)
Furrer, Julienorcid-logo
DCBP Gruppe Prof. Furrer
Departement für Chemie, Biochemie und Pharmazie (DCBP) Universität Bern
Hilty, Markusorcid-logo
Institut für Infektionskrankheiten (IFIK) - Forschung
Institut für Infektionskrankheiten (IFIK) - Microbiome
Institut für Infektionskrankheiten (IFIK)
Additional Credits
Institut für Infektionskrankheiten (IFIK) - Forschung
Institut für Infektionskrankheiten, Labor für Klinische Pharmakologie
DCBP Gruppe Prof. Furrer
Institut für Infektionskrankheiten (IFIK) - Microbiome
Series
Frontiers in cellular and infection microbiology
Publisher
Frontiers
ISSN
2235-2988
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo